Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
JAMA Surgery
|
November 27, 2014
Management of symptomatic polycystic liver disease with hepatic resection
Jennifer Tseng, Susan L Orloff
JAMA Surgery
|
October 6, 2016
Promise and Pitfalls of Using α-Fetoprotein in Liver Transplantation Allocation for Hepatocellular Carcinoma
Barry Schlansky, Susan L Orloff
Annals of Surgery
|
December 19, 2019
Locoregional Therapy, Pathologic Response, and HCC Recurrence After Liver Transplantation: Highlighting Success and Looking Toward the Future
C Kristian Enestvedt, Susan L Orloff
JAMA Surgery
|
May 21, 2020
Sex Does Matter in Liver Allocation-Time to Address Existing Sex-Based Disparities
Willscott E Naugler, Susan L Orloff
Transplantation
|
February 21, 2018
Ganja, No Barrier for Liver Transplantation?
Willscott E Naugler, Susan L Orloff
Hepatic Oncology
|
September 8, 2018
Who should undergo liver transplantation for hepatocellular carcinoma? Ablate, wait … and see!
Willscott E Naugler, Barry Schlansky, Susan L Orloff
Virus Research
|
September 28, 2010
The role of cytomegalovirus in angiogenesis
Patrizia Caposio, Susan L Orloff, Daniel N Streblow
Transplantation
|
June 19, 2013
An unusual presentation of altered mental status after orthotopic liver transplantation: Listeria brain abscess
Jennifer Tseng, Lynne M Strasfeld, Susan L Orloff
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 22, 2013
Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant
Ilia Gur, Brian S Diggs, Susan L Orloff
JAMA Surgery
|
October 23, 2024
Limitations in Gauging the Effects of Allocation Policy Changes on Liver Transplant-Reply
Maria Bernadette Majella Doyle, Ola Ahmed, Susan L Orloff
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
JAMA Surgery
|
November 27, 2014
Management of symptomatic polycystic liver disease with hepatic resection
Jennifer Tseng, Susan L Orloff
JAMA Surgery
|
October 6, 2016
Promise and Pitfalls of Using α-Fetoprotein in Liver Transplantation Allocation for Hepatocellular Carcinoma
Barry Schlansky, Susan L Orloff
Annals of Surgery
|
December 19, 2019
Locoregional Therapy, Pathologic Response, and HCC Recurrence After Liver Transplantation: Highlighting Success and Looking Toward the Future
C Kristian Enestvedt, Susan L Orloff
JAMA Surgery
|
May 21, 2020
Sex Does Matter in Liver Allocation-Time to Address Existing Sex-Based Disparities
Willscott E Naugler, Susan L Orloff
Transplantation
|
February 21, 2018
Ganja, No Barrier for Liver Transplantation?
Willscott E Naugler, Susan L Orloff
Hepatic Oncology
|
September 8, 2018
Who should undergo liver transplantation for hepatocellular carcinoma? Ablate, wait … and see!
Willscott E Naugler, Barry Schlansky, Susan L Orloff
Virus Research
|
September 28, 2010
The role of cytomegalovirus in angiogenesis
Patrizia Caposio, Susan L Orloff, Daniel N Streblow
Transplantation
|
June 19, 2013
An unusual presentation of altered mental status after orthotopic liver transplantation: Listeria brain abscess
Jennifer Tseng, Lynne M Strasfeld, Susan L Orloff
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 22, 2013
Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant
Ilia Gur, Brian S Diggs, Susan L Orloff
JAMA Surgery
|
October 23, 2024
Limitations in Gauging the Effects of Allocation Policy Changes on Liver Transplant-Reply
Maria Bernadette Majella Doyle, Ola Ahmed, Susan L Orloff
Page
of 7